Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
A clinical trial to determine the effectiveness and safety of AUY922 compared to other drugs
known to be effective against gastric cancer in second line therapy for patients who have
failed one line of chemotherapy.